Skip to main content

Select Drug Profiles

Conference Highlights ASH

Vincristine Sulfate Liposome Injection (Marqibo) and Rituximab for Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma in Need of Palliative Therapy

Foreward - The Fifth Annual Payers’ Guide to New FDA Approvals

Introduction - New FDA Drug Approvals in 2013

Gary M. Owens, MD

FDA Approvals of Brand-Name Prescription Drugs in 2013

Specialty Drugs Top the Trends in the 2014 Pipeline

Dalia Buffery, MA, ABD

Abraxane (nab-Paclitaxel) Receives a New Indication for the Treatment of Patients with Metastatic Pancreatic Cancer

Lisa A. Raedler, PhD, RPh

Adempas (Riociguat): A Novel, First-in-Class Therapy Approved for the Treatment of 2 Types of Pulmonary Hypertension

Lisa A. Raedler, PhD, RPh

Amitiza (Lubiprostone): The First Oral Treatment Approved by the FDA for Opioid-Induced Constipation

Anoro Ellipta (Umeclidinium/Vilanterol): First Dual Long-Acting Inhaler for Long-Term Maintenance Treatment of COPD

Lisa A. Raedler, PhD, RPh

Botox (OnabotulinumtoxinA) Now FDA Approved for Overactive Bladder

Page 152 of 244
Results 1511 - 1520 of 2438